Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793623 · ClinicalTrials.gov registry record
Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 37
- Enrollment target
NCT01793623: Completed study, sponsored by University of Pittsburgh.
NCT01793623 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01793623 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
Over the past decade, techniques have been refined which permit an enormous amount of information relevant to disease mechanisms to be gained from the examination of heart tissue. The Cardiovascular Institute has extensive experience with these techniques, and has utilized them to examine other heart disease substrates. In this study, the investigators propose to obtain heart tissue at the time of cardiac surgery which would otherwise be discarded. Their plan is to examine this tissue and correlate their findings with clinical data. Their hope is that the proposed study will provide insight into atrial physiology, including the molecular mechanisms underlying atrial disease and the potential development of atrial fibrillation (AF).
Primary Outcome
Normally discarded atrial tissue samples will be collected at the time of cardiac surgery and microscopic histology will be performed using standard tissue stains
Interventions
- OTHER atrial tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-12-11 |
| Est. Completion | 2016-02-17 |
What the finished NCT01793623 record still lists
NCT01793623 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which atrial tissue is the first listed.
NCT01793623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01793623 about?
NCT01793623 is a clinical study titled "Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking". Over the past decade, techniques have been refined which permit an enormous amount of information relevant to disease mechanisms to be gained from the examination of heart tissue. The Cardiovascular Institute has extensive experience with these techniques, and has utilized them to examine other hear...
What is the current status of trial NCT01793623?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2012-12-11. Estimated completion is 2016-02-17.
What interventions are being tested in trial NCT01793623?
The interventions under investigation include: atrial tissue (OTHER).
Who is sponsoring clinical trial NCT01793623?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI